Retraction of: Use of Decellularized Scaffolds Combined with Hyaluronic Acid and Basic Fibroblast Growth Factor for Skin Tissue Engineering by Wu A, Fan L, Xu B, Lin Y, Zhang P, and Wei X. Tissue Eng 2015;21(1-2):390-402. DOI: 10.1089/ten.tea.2013.0260;Use of decellularized scaffolds combined with hyaluronic acid and basic fibroblast growth factor for skin tissue engineering

Tissue Engineering - Part A

Volumn 21, Issue 1-2, 2015, Pages 390-402

  Wu, Zhengzheng ^a   Fan, Lina ^b   Xu, Bin ^c   Lin, Yongliang ^c   Zhang, Peng ^c   Wei, Xing ^a  

^a JINAN UNIVERSITY   (China)

^b SHANTOU UNIVERSITY   (China)

^c Grandhope Biotech Co Ltd   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOACTIVITY; CELL CULTURE; DERMATOLOGY; FIBROBLASTS; HYALURONIC ACID; MAMMALS; ORGANIC ACIDS; TISSUE; TISSUE REGENERATION;

BASIC FIBROBLAST GROWTH FACTOR; BIOCHEMICAL TREATMENTS; CLINICAL SKIN DISEASE; DECELLULARIZED; SKIN TISSUE ENGINEERING; STUDENT'S T TESTS; TISSUE SCAFFOLDS; WOUND HEALING;

SCAFFOLDS (BIOLOGY);

FIBROBLAST GROWTH FACTOR 2; HYALURONIC ACID; LIQUID PARAFFIN; SOLUTION AND SOLUBILITY;

3T3 CELL LINE; ADSORPTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DECELLULARIZED SCAFFOLD; DERMIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL PIG; GRANULATION TISSUE; IN VITRO STUDY; NONHUMAN; PERITONEUM; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SKIN GRAFT; SKIN INJURY; SKIN TRANSPLANTATION; SKINFOLD THICKNESS; STUDENT; TISSUE ENGINEERING; TISSUE REGENERATION; TISSUE SCAFFOLD; WOUND HEALING; ANIMAL; CELL DEATH; CHEMISTRY; DRUG EFFECTS; MOUSE; PIG; PROCEDURES; RABBIT; SOLUTION AND SOLUBILITY; STAINING; SURGERY;

ORYCTOLAGUS CUNICULUS; SUIDAE;

ANIMALS; CELL DEATH; DERMIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROBLAST GROWTH FACTOR 2; HYALURONIC ACID; MICE; MICROSCOPY, ELECTRON, SCANNING; NIH 3T3 CELLS; RABBITS; SOLUTIONS; STAINING AND LABELING; SUS SCROFA; TISSUE ENGINEERING; TISSUE SCAFFOLDS; WOUND HEALING;

EID: 84921377875     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2013.0260.retract     Document Type: Erratum

References (46)

1. Brohem, C.A., da Silva Cardeal, L.B., Tiago, M., Soengas, M.S., de Moraes Barros, S.B., and Maria-Engler, S.S. Artificial skin in perspective: concepts and applications. Pigment Cell Melanoma Res 24, 35, 2011.
2. Kondo, T., and Ishida, Y. Molecular pathology of wound healing. Forensic Sci Int 203, 93, 2010.
3. Larson, B.J., Longaker, M.T., and Lorenz, H.P. Scarless fetal wound healing: a basic science review. Plast Reconstr Surg 126, 1172, 2010.
4. van der Veen, V.C., van der Wal, M.B.A., van Leeuwen, M.C.E., Ulrich, M.M.W., and Middelkoop, E. Biological background of dermal substitutes. Burns 36, 305, 2010.
5. Huang, S., and Fu, X. Naturally derived materials-based cell and drug delivery systems in skin regeneration. J Control Release 142, 149, 2010.
6. Rodero, M.P., and Khosrotehrani, K. Skin wound healing modulation by macrophages. Int J Clin Exp Pathol 3, 643, 2010.
7. Sen, C.K., Gordillo, G.M., Roy, S., Kirsner, R., Lambert, L., Hunt, T.K., et al. Human skin wounds: a major and snowballing threat to public health and the economy. Wound Repair Regen 17, 763, 2009.
8. Wong, V.W., and Gurtner, G.C. Tissue engineering for the management of chronic wounds: current concepts and future perspectives. Exp Dermatol 21, 729, 2012.
9. Akhundov, K., Pietramaggiori, G., Waselle, L., Darwiche, S., Guerid, S., Scaletta, C., et al. Development of a cost-effective method for platelet-rich plasma (PRP) preparation for topical wound healing. Ann Burns Fire Disasters 207, 25, 2012.
10. Li, J., Chen, J., and Kirsner, R. Pathophysiology of acute wound healing. Clin Dermatol 9, 25, 2007.
11. Young, A., and McNaught, C.E. The physiology of wound healing. Surgery (Oxford) 475, 10, 2011.
12. Nguyen, D.Q.A., Potokar, T.S., and Price, P. An objective long-term evaluation of Integra (a dermal skin substitute) and split thickness skin grafts, in acute burns and reconstructive surgery. Burns 36, 23, 2010.
13. Shirakigawa, N., Ijima, H., and Takei, T. Decellularized liver as a practical scaffold with a vascular network template for liver tissue engineering. J Biosci Bioeng 114, 546, 2012.
14. Zang, M., Zhang, Q., Chang, E.I., Mathur, A.B., and Yu, P. Decellularized tracheal matrix scaffold for tissue engineering. Plast Reconstr Surg 130, 532, 2012.
15. Ting, T.S., Hashimoto, H.Y., Kishida, K.A., Ushida, U.T., and Furukawa, F.K. High-hydrostatic pressurization de-cellularized bovine articular cartilage scaffolds for cartilage tissue engineering. J Tissue Eng Regen Med 6, 74, 2012.
16. Ye, Q., Wang, J., Deng, V., Kaplunovsky, A., Bhatia, M., Hofgartner, W., et al. Decellularized human placental vascular scaffold provides a platform for tissue and orga-noid engineering. J Tissue Eng Regen Med 6, 169, 2012.
17. Mangold, S., Schrammel, S., Huber, G., Schmid, C., Liebold, A., and Hoenicka, M. Comparison of denuded and decellularized human umbilical vein as scaffolds for vascular tissue engineering. J Tissue Eng Regen Med 6, 174, 2012.
18. Sun, T., Han, Y., Chai, J., and Yang, H. Transplantation of microskin autografts with overlaid selectively decellular-ized split-thickness porcine skin in the repair of deep burn wounds. J Burn Care Res 32, e67, 2011.
19. Wainwright, D.J., and Bury, S.B. Acellular dermal matrix in the management of the burn patient. Aesthet Surg J 31, 13S, 2011.
20. Patel, K.M., Nahabedian, M.Y., Gatti, M., and Bhanot, P. Indications and outcomes following complex abdominal reconstruction with component separation combined with porcine acellular dermal matrix reinforcement. Ann Plast Surg 69, 394, 2012.
21. Heybeli, T., Kulacoglu, H., Genc, V., Ergul, Z., Ensari, C., Kiziltay, A., et al. Basic fibroblast growth factor loaded polypropylene meshes in repair of abdominal wall defects in rats. Chirurgia (Bucur) 105, 809, 2010.
22. Yang, Y., Xia, T., Zhi, W., Wei, L., Weng, J., Zhang, C., et al. Promotion of skin regeneration in diabetic rats by electrospun core-sheath fibers loaded with basic fibroblast growth factor. Biomaterials 32, 4243, 2011.
23. Yang, Y., Xia, T., Chen, F., Wei, W., Liu, C., He, S., et al. Electrospun fibers with plasmid bFGF polyplex loadings promote skin wound healing in diabetic rats. Mol Pharm 9, 48, 2012.
24. Ayvazyan, A., Morimoto, N., Kanda, N., Takemoto, S., Kawai, K., Sakamoto, Y., et al. Collagen-gelatin scaffold impregnated with bFGF accelerates palatal wound healing of palatal mucosa in dogs. J Surg Res 171, e247, 2011.
25. Ferguson, E.L., Alshame, A.M.J., and Thomas, D.W. Evaluation of hyaluronic acid-protein conjugates for polymer masked-unmasked protein therapy. Int J Pharm 402, 95, 2010.
26. Slavkovsky, R., Kohlerova, R., Jiroutova, A., Hajzlerova, M., Sobotka, L., Cermakova, E., et al. Effects of hyalur-onan and iodine on wound contraction and granulation tissue formation in rat skin wounds. Clin Exp Dermatol 35, 373, 2010.
27. Gao, F., Liu, Y., He, Y., Yang, C., Wang, Y., Shi, X., et al. Hyaluronan oligosaccharides promote excisional wound healing through enhanced angiogenesis. Matrix Biol 29, 107, 2010.
28. Galeano, M., Polito, F., Bitto, A., Irrera, N., Campo, G.M., Avenoso, A., et al. Systemic administration of high-molecular weight hyaluronan stimulates wound healing in genetically diabetic mice. Biochim Biophys Acta 1812, 752, 2011.
29. Anilkumar, T.V., Muhamed, J., Jose, A., Jyothi, A., Mo-hanan, P.V., and Krishnan, L.K. Advantages of hyaluronic acid as a component of fibrin sheet for care of acute wound. Biologicals 39, 81, 2011.
30. Hu, D.H., Zhang, Z.F., Zhang, Y.G., Zhang, W.F., Wang, H.T., Cai, W.X., et al. A potential skin substitute constructed with hEGF gene modified HaCaT cells for treatment of burn wounds in a rat model. Burns 38, 702, 2012.
31. Choi, J.K., Jang, J.H., Jang, W.H., Kim, J., Bae, I.H., Bae, J., et al. The effect of epidermal growth factor (EGF) conjugated with low-molecular-weight protamine (LMWP) on wound healing of the skin. Biomaterials 33, 8579, 2012.
32. Song, R., Bian, H.N., Lai, W., Chen, H.D., and Zhao, K.S. Normal skin Normal skin and hypertrophic scar fibroblasts differentially regulate collagen and fibronectin expression as well as mitochondrial membrane potential in response to basic fibroblast growth factor. Braz J Med Biol Res 44, 402, 2011.
33. Ackermann, M., Wolloscheck, T., Wellmann, A., Li, V.W., Li, W.W., and Konerding, M.A. Priming with a combination of proangiogenic growth factors improves wound healing in normoglycemic mice. Int J Mol Med 27, 647, 2011.
34. Iyyam Pillai, S., Palsamy, P., Subramanian, S., and Kan-daswamy, M. Wound healing properties of Indian propolis studied on excision wound-induced rats. Pharm Biol 48, 1198, 2010.
35. Leclerc, T., Thepenier, C., Jault, P., Bey, E., Peltzer, J., Trouillas, M., et al. Cell therapy of burns. Cell Prolif 44, 48, 2011.
36. Lataillade, J.J., Bey, E., Thepenier, C., Prat, M., Leclerc, T., and Bargues, L. Skin engineering for burns treatment. Bull Acad Natl Med 194, 1339, 2010.
37. Malkowski, A., Sobolewski, K., Jaworski, S., and Bank-owski, E. FGF binding by extracellular matrix components of Wharton's jelly. Acta Biochim Pol 54, 357, 2007.
38. Horch, R.E., Kopp, J., Kneser, U., Beier, J., and Bach, A.D. Tissue engineering of cultured skin substitutes. J Cell Mol Med 9, 592, 2005.
39. Dobrzycka, B., Mackowiak-Matejczyk, B., Kinalski, M., and Terlikowski, S.J. Pretreatment serum levels of bFGF and VEGF and its clinical significance in endometrial carcinoma. Gynecol Oncol 128, 454, 2013.
40. Szarvas, T., Jäger, T., Laszlo, V., Kramer, G., Klingler, H.C., vom Dorp, F., et al. Circulating angiostatin, bFGF, and Tie2/TEK levels and their prognostic impact in bladder cancer. Urology 80, 737.e13, 2012.
41. Bremnes, R.M., Camps, C., and Sirera, R. Angiogenesis in non-small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood. Lung Cancer 51, 143, 2006.
42. Lee, J., Kotliarova, S., Kotliarov, Y., Li, A., Su, Q., Donin, N.M., et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phe-notype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9, 391, 2006.
43. Sun, B., Xu, H., Zhang, G., Zhu, Y., Sun, H., and Hou, G. Basic fibroblast growth factor upregulates survivin expression in hepatocellular carcinoma cells via a protein kinase B-dependent pathway. Oncol Rep 30, 385, 2013.
44. Li, S.H., Cai, S.X., Liu, B., Ma, K.W., Wang, Z.P., and Li, X.K. In vitro characteristics of poly (lactic-co-glycolic acid) microspheres incorporating gelatin particles loading basic fibroblast growth factor. Acta Pharmacol Sin 27, 754, 2006.
45. Skaat, H., Ziv-Polat, O., Shahar, A., and Margel, S. Enhancement of the growth and differentiation of nasal olfactory mucosa cells by the conjugation of growth factors to functional nanoparticles. Bioconjug Chem 22, 2600, 2011.
46. Nie, S.P., Wang, X., Qiao, S.B., Zeng, Q.T., Jiang, J.Q., Liu, X.Q., et al. Improved myocardial perfusion and cardiac function by controlled-release basic fibroblast growth factor using fibrin glue in a canine infarct model. J Zhejiang Univ Sci B 11, 895, 2010.